Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-03
1997-11-11
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514267, 544280, 544250, A61K 31505, C07D40302
Patent
active
056864574
ABSTRACT:
The invention relates to the use of the compounds mentioned below in the therapeutic treatment of tumour diseases and other proliferative diseases, such as psoriasis, and to novel compounds of that type. The compounds are compounds of formula I ##STR1## wherein n is from 0 to 5 and, when n is not 0,
REFERENCES:
patent: 3037980 (1962-06-01), Hitchings et al.
patent: 3311628 (1967-03-01), Partyka
patent: 3631045 (1971-12-01), Kim et al.
patent: 4229453 (1980-10-01), Roth et al.
patent: 5034393 (1991-07-01), Hackler et al.
patent: 5256650 (1993-10-01), Peet et al.
patent: 5350749 (1994-09-01), Hackler et al.
patent: 5496822 (1996-03-01), Akimoto et al.
Chem. 22:859 (1985).
Jorgensen et al. "Phosphorus Pentoxide in Organic Synthesis, XII Synthesis (1985).
Girgis et al. "Phosphorus Pentoxide in Organic Synthesis; XI: A New Synthetic Approach to 7-Deazahypoxanthines" Synthesis (1): 101-104 (1985).
Girgis et al., Liebigs Ann. Chem. (1983) 2066-2072.
Jorgenson et al "Phosphorus Pentoxide in Organic Synthesis" Chem. Scripta 25, 222-226. (1985).
Marquet et al., Chimie Therapeutique 6, 427-438 (1971).
Brill Wolfgang K.-D.
Furet Pascal
Traxler Peter
Ferraro Gregory D.
Grumbling Matthew V.
Novartis Corporation
LandOfFree
Pyrrolopyrimidine derivatives having pharmacological activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyrimidine derivatives having pharmacological activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyrimidine derivatives having pharmacological activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1229389